A hamartoma is a benign malformation of native tissue that may occur in any area of the body. Hamartoma of the tongue is a rare developmental lesion. We describe the case of a pendulant lingual hamartoma in a 2-day-old girl that had not been identified on prenatal ultrasonography. We also review the utility of prenatal imaging options, the role of preoperative imaging, the mechanical relationship between lingual hamartoma and cleft palate, the histopathology of this tumor, surgical treatment, and emergency airway management.
Introduction
A lingual hamartoma, first described by Stamm and Tauber 1 in 1945, is a rare benign congenital malformation of the tongue. This growth is usually located on the posterior dorsal surface. A lingual hamartoma can be an isolated finding or occur with other signs as part of a syndrome. To provide optimal care, the physician must reach a definitive diagnosis, which may prompt additional diagnostic studies if there is a suspicion of known syndromes.
We describe a new case of lingual hamartoma, and we discuss the utility of prenatal imaging options, the role of preoperative imaging, the mechanical relationship between lingual hamartoma and cleft palate, the need to look for potential airway obstruction, the role of surgical excision for a definitive diagnosis, the histopathology of this tumor, and emergency airway management.
Case report A 2-day-old girl was seen in consultation for evaluation of a tongue mass that had been observed during the newborn examination. She had been born to a 38-yearold gravida 1 para 1 mother via caesarean delivery at 41 weeks and 3 days; the caesarean delivery was necessitated by the fetus's failure to progress. The infant had no history of neonatal respiratory distress and no identified dysmorphic feature. She failed to initiate any oral feeding after multiple attempts.
Examination of the oral cavity and oropharynx revealed a U-shaped complete cleft of the secondary palate. A smooth, pedunculated tongue mass measuring 2.0 × 2.0 cm was noted, as well. The mass was attached to the posterior two-thirds of the tongue, and it valved in and out of the hypopharynx. Ultrasonography (US) of the neck revealed a normal-appearing thyroid gland.
The patient was taken to the operating theater on day 2 of life for surgical excision of the mass (figure 1). A lingual frenotomy was also performed secondary to ankyloglossia. The patient was extubated without incident.
Findings on histopathologic analysis were consistent with a lingual hamartoma (figure 2). The patient did well postoperatively, although she was noted to have intermittent choking with oral feeds. A videofluoroscopic swallow study on postoperative day 3 was remarkable for silent aspiration, inefficient suck, and moderate nasopharyngeal regurgitation. A percutaneous gastrostomy tube was placed for enteral access on the 18th day of life because of the patient's poor swallow, aspiration, and failure to thrive. Oral feeding was gradually introduced and swallow therapy was undertaken, and she was able to feed orally without issues by the age of 10 months.
Discussion
A lingual hamartoma is a benign mass composed of abnormally arranged cells and tissue endogenous to the tongue. On clinical examination, it can be sessile or pedunculated. Its characteristic histopathologic features include the presence of epithelial and mesenchymal elements, including fibrovascular tissue, adipocytes, smooth muscle, neurovascular tissue, salivary glands, and stratified squamous epithelium. 2, 3 A lingual hamartoma should not be confused with a choristoma, which is made up of normally arranged tissue found in a nonnative anatomic site.
The histogenesis of hamartomatous tongue lesions in children is unknown, but concomitant cleft palate is a common association. 2, 4 This association may be attributed to the mechanical relationship between the two during embryologic development. The tongue is derived from the first through fourth pharyngeal arches. The anterior two-thirds of the tongue is formed with contributions from the first pharyngeal arch, including two lateral lingual prominences and the tuberculum impar. The posterior one-third arises from the second and third pharyngeal arches, with a contribution from the fourth. These parts fuse at the terminal sulcus beginning in the fourth week of gestation. 2, 4 Development of the palate is initiated during the fifth week. Therefore, a failure of the embryologic precursors of the tongue to fuse may lead to the formation of lingual anomalies that mechanically prevent proper morphogenesis of the palate.
A discovery of multiple lingual hamartomas should prompt consideration of other abnormalities that are seen in oral-facial-digital syndrome. 5 These include cleft lip or palate, hypertelorism, digital abnormalities, and cerebellar abnormalities. Although multiple hamartoma syndrome (Cowden syndrome) may involve hamartomas of the oral cavity, a lingual hamartoma is rarely seen. 2 In our case, there was a low suspicion of syndromes and an absence of syndromic features, and therefore no further testing was performed.
The differential diagnosis of focal masses of the tongue in children include lingual thyroid, thyroglossal duct cyst, ranula, choristoma, foregut duplication cyst, neurofibroma, fibromatosis, and neoplasms such as sarcoma and teratoma. 2, 3, 6 Preoperative US, magnetic resonance imaging (MRI), and computed tomography are instrumental in identifying the presence of a thyroid gland or other anatomic anomaly. Furthermore, these tools help in delineating the extent of a mass as the surgeon develops a preoperative plan.
MRI is the study of choice when soft-tissue resolution is desired for investigating the infiltration of a mass into surrounding tissue. 2, 6 On MRI, lingual hamartomas tend to demonstrate hypointensity on T1-weighted imaging and hyperintensity on T2-weighted imaging, but mixed signal intensity is not unexpected on T2-weighted images because of the variabilities in tissue composition that are unique to different patients. 2 The use of high-resolution prenatal US has increased the rate at which tongue masses are being discovered. 7 Other US findings may suggest upper airway obstruction in the context of a suspected lesion; these include oligohydramnios, echogenic lungs, a flattened diaphragm, and/or dilation of the distal airway anatomy. The visualization of a tongue mass in combination with other findings should heighten the suspicion of airway obstruction at delivery. In response, a multidisciplinary delivery team can be formed to provide emergency airway management; such a team should include physicians in the fields of obstetrics, neonatology, anesthesiology, and otolaryngology. composed of pleomorphic to bizarre nuclei, coarse chromatin, and frequent mitoses (including atypical forms) focally arranged in storiform patterns met the diagnostic criteria for an MFH as the postcricoid tumor ( figure 3, A) . The biopsies of the piriform sinus and posterior pharyngeal wall were consistent with a poorly differentiated SCC ( figure 3, B) . The biopsy of the esophageal mucosa revealed SCC (in situ). On the basis of a complete cancer survey, the tumors in the hypopharynx and esophagus were staged as T3N0M0 and T1N0M0, respectively.
The patient's postoperative course was uneventful.
Decannulation was achieved 4 days following the biopsies. Chemoradiotherapy was started with the intent to preserve the hypopharynx. The patient achieved a complete remission, and he remained disease-free at 23 months of follow-up.
Since the 1990s, large randomized trials have provided evidence that laryngeal preservation strategies with concurrent chemo-and radiotherapy or induction chemotherapy followed by radiotherapy is as effective as initial total laryngectomy in terms of survival. 6,7 However, a secondary cancer with different histology represents a special clinical situation, which should be studied separately.
Limited by the small number of reported cases, consensus has not been reached and the treatment of synchronous double cancers with different histology still represents a challenge. With little to go on, it appears that the relatively large series of patients with synchronous MFH and SCC reported by Ferlito 8 (N = 9) will serve as the basis for information on the treatment and pathogenesis of double cancer in a single anatomic site.
Synchronous or metachronous multiple primary cancers with similar histology at the same site or within the same organ system are not uncommon. The incidence of this phenomenon is especially high in the head and neck in areas such as the oral cavity, pharynx, larynx, and esophagus. 9,10 However, synchronous double cancers with dissimilar histology at one site are very rare. To the best of our knowledge, only 23 such cases have been previously reported in the literature (table) . 5, 8, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] Of these, only 1 involved the hypopharynx alone 17 and 1 involved the larynx and hypopharynx. 22 The histogenesis of MFH differs greatly from that of SCC. MFH is a malignant mesenchymal tumor, while SCC has an ectodermal origin. The nature of their relationship in these cases is obscure. Slaughter et al described the concept of "field cancerization" to explain the presence of multiple cancers with similar histology occurring synchronously or metachronously in the same organ system. 28 According to this concept, the same carcinogen could affect the entire epithelium of the upper aerodigestive tract and result in panmucosal disease. In our case, however, this concept might not be applicable because the oncotype of the two tumors was embryonically different.
MFH of the head and neck is uncommon, with most cases occurring secondary to radiation therapy. 29, 30 Alcoholism is one of the important causes of SCC of the hypopharynx, and smoking is one of the important causes of SCC of the larynx. Our patient was a social drinker with no history of radiation exposure, and thus we are unable to adequately explain the pathogenesis of his disease.
No consensus has been reached with respect to the treatment of synchronous double cancers of dissimilar oncotypes in the larynx and hypopharynx. The concept of laryngeal preservation was not stressed in the 1970s and 1980s, when Ferlito initially reported his cases, because it was not necessarily a primary goal of treatment then. He and colleagues reported that 3 of 4 patients with a non-SCC synchronous second cancer who underwent laryngectomy as the initial treatment died of their disease at 3.5, 17 13, 5 and 14 months, 8 respectively. Another patient with laryngeal SCC who underwent a partial laryngectomy survived for 7 years, but the metachronous occurrence of small-cell carcinoma (oat-cell carcinoma) did not respond to surgery plus radiation, and the patient died 20 months after the onset of the second cancer.
Surgery as an initial treatment did not appear to prolong survival in Ferlito's 1980 report. 8 However, in a later report by Ferlito et al 19 and in a report by Medina-Banegas et al, 24 total laryngectomy performed as the initial treatment resulted in disease-free follow-up at 3.5 years and 6 years, respectively.
Surgery for MFH may require a wide tumor-free margin because local recurrence rates are relatively high. Hardison et al reported a median disease-free survival rate of 20 months and a 5-year disease-free survival rate of 37%. 31 In our case, the proximity of the MFH to the posterior cricoarytenoid muscle and the recurrent laryngeal nerve provided a challenge to the feasibility of laser surgery. Considering the desire to preserve organ function, radical extirpation should be a last resort, even though chemoradiotherapy has limited efficacy because these tumors have a low degree of radiosensitivity.
